• Contemporary ClinicContemporary Clinic
  • OTC GuideOTC Guide
  • Pharmacy Times
  • PTCEPTCE
  • Pharmacist Moms GroupPharmacist Moms Group
News
All News
FDA Updates
Press Releases
Media
All Videos
Digital Detail
Independent Corner
Insights
Interviews
MEDcast
Medical World News
Microsites
Peer Exchange
Perfect Consult
Podcasts
Practice Pearls
Sponsored Webcast
Student Voices
Webinars/Webcasts
Conferences
Conference Coverage
Conference Listing
Publications
Pharmacy Times
Pharmacy Practice in Focus: Oncology
Pharmacy Practice in Focus: Health Systems
Pharmacy Careers
All Publications
About the Publications
Author Submission
Submit to Pharmacy Practice in Focus: Oncology
Submit to Pharmacy Practice in Focus: Health Systems
Become a Peer Reviewer
Supplements & Featured Publications
Clinical
503B Compounding Pharmacy
ADHD
Allergy
Alzheimer Disease
Anxiety
Asthma
Atopic Dermatitis
Biosimilars
Bipolar Disorder
Brain Health
Breast Cancer
C. Difficile
COPD
COVID-19
Cardiovascular Health
Cervical Cancer
Cholangiocarcinoma
Cholesterol
Chronic Kidney Disease
Chronic Lymphocytic Leukemia
Classical Hematology
Colorectal Cancer
Continuous Glucose Monitoring
Cough and Cold
Depression
Dermatology
Diabetes
Digestive Health
Dry Eye Disease
Epilepsy
Eye Care
Flu
Future of Pharmacy
Gastrointestinal Cancer
Gastrointestinal Health
Gout
HER2 Breast Cancer
HIV
Heart Failure
Hematology
Hepatitis/MASH
Immunization
Immuno-oncology
Immunoglobulins
Infectious Disease
Lung Cancer
Lymphoma
Macular Degeneration
Mental Health
Migraine
Movement Disorders
Multiple Myeloma
Multiple Sclerosis
Myelofibrosis
Neurology
Neutropenia
Osteoporosis
Ovarian Cancer
Pain Management
Parkinson Disease
Pediatrics
Pharmacy Heroes
Pharmacy Management
Pneumococcal
PrEP
Prostate Cancer
Psoriasis
Psoriatic Arthritis
Psychedelics
Reimbursement
Reproductive Health
Respiratory Syncytial Virus
Rheumatoid Arthritis
Schizophrenia
Shingles
Skin Cancer
Sleep
Travel Vaccines
Veterinary Pharmacy
Vitamins and Supplements
Weight Management
Women's Health
Events
Upcoming Events
Upcoming Webinars
CE
Resources
Clinical Forum
Cou-Co
Educated Patient
Information for the Pharmacist
Interactive Tools
Partners
Sponsored
Whiteboards
Subscribe
logo
Spotlight
Community/RetailHospitalOncologyPharmacy TechnicianStudent
Clinical Role
Community/RetailHospitalOncologyPharmacy TechnicianSpecialty PharmacyStudent
Clinical
CoronavirusBrain HealthCardiovascular HealthDermatologyDiabetesFluHeart FailureHepatitis/MASHImmunizationMigrainePneumococcalVitamins and Supplements
Supplement Spotlight
October 2023 Pharmacy Technician Edition
All News
FDA Updates
Press Releases
All Videos
Digital Detail
Independent Corner
Insights
Interviews
MEDcast
Medical World News
Microsites
Peer Exchange
Perfect Consult
Podcasts
Practice Pearls
Sponsored Webcast
Student Voices
Webinars/Webcasts
Conference Coverage
Conference Listing
Pharmacy Times
Pharmacy Practice in Focus: Oncology
Pharmacy Practice in Focus: Health Systems
Pharmacy Careers
All Publications
About the Publications
Author Submission
Submit to Pharmacy Practice in Focus: Oncology
Submit to Pharmacy Practice in Focus: Health Systems
Become a Peer Reviewer
Supplements & Featured Publications
503B Compounding Pharmacy
ADHD
Allergy
Alzheimer Disease
Anxiety
Asthma
Atopic Dermatitis
Biosimilars
Bipolar Disorder
Brain Health
Breast Cancer
C. Difficile
COPD
COVID-19
Cardiovascular Health
Cervical Cancer
Cholangiocarcinoma
Cholesterol
Chronic Kidney Disease
Chronic Lymphocytic Leukemia
Classical Hematology
Colorectal Cancer
Continuous Glucose Monitoring
Cough and Cold
Depression
Dermatology
Diabetes
Digestive Health
Dry Eye Disease
Epilepsy
Eye Care
Flu
Future of Pharmacy
Gastrointestinal Cancer
Gastrointestinal Health
Gout
HER2 Breast Cancer
HIV
Heart Failure
Hematology
Hepatitis/MASH
Immunization
Immuno-oncology
Immunoglobulins
Infectious Disease
Lung Cancer
Lymphoma
Macular Degeneration
Mental Health
Migraine
Movement Disorders
Multiple Myeloma
Multiple Sclerosis
Myelofibrosis
Neurology
Neutropenia
Osteoporosis
Ovarian Cancer
Pain Management
Parkinson Disease
Pediatrics
Pharmacy Heroes
Pharmacy Management
Pneumococcal
PrEP
Prostate Cancer
Psoriasis
Psoriatic Arthritis
Psychedelics
Reimbursement
Reproductive Health
Respiratory Syncytial Virus
Rheumatoid Arthritis
Schizophrenia
Shingles
Skin Cancer
Sleep
Travel Vaccines
Veterinary Pharmacy
Vitamins and Supplements
Weight Management
Women's Health
Upcoming Events
Upcoming Webinars
CE
Clinical Forum
Cou-Co
Educated Patient
Information for the Pharmacist
Interactive Tools
Partners
Sponsored
Whiteboards
Subscribe
Advertisement

CLINICAL ROLE -

Community/Retail
| Hospital
| Oncology
| Pharmacy Technician
| Student

Article

December 28, 2017

Nearly Half of Cancers, Related Deaths Are Preventable

Author(s):

Laurie Toich, Assistant Editor

Cigarette smoking played a role in 19% of cancers and 29% of cancer-related deaths in 2014.

It is well-known that certain modifiable risk factors—including diet and smoking—can prevent the development of cancer. New data published by CA: A Cancer Journal of Clinicians suggests that nearly half of cancer cases and cancer-related deaths are preventable.

Based on current cancer rates, the authors estimated that 42% of cancer cases and 45% of cancer deaths are associated with modifiable risk factors.

In 2014 specifically, 659,640 out of 1.6 million cancer cases and 265,150 out of 587,521 cancer deaths were preventable, according to the study.

The authors calculated how much modifiable lifestyle behaviors contributed to the risk of 26 different cancers among adults 30 years of age and older. Risk factors included:

· smoking

· secondhand smoke

· excess weight

· alcohol consumption

· eating red meat

· not eating enough fruits, vegetable, fiber, and calcium

· a lack of exercise

· UV radiation

· infections with Helicobacter pylori, hepatitis B virus, hepatitis C virus, human herpes virus type 8, HIV, and human papillomavirus (HPV)

The authors first examined the prevalence of the factors and their relative risk to determine the prevalence of associated cancers. The researchers then applied the estimates to actual cancer diagnosis and mortality data.

The authors said that their study improves upon previous research since they included additional risk factors and up-to-date national data.

Although cancer mortality rate has dropped 25% since 1991, the American Cancer Society projects that more than 1.6 million cancers and 600,000 deaths will occur in 2017. The authors note their findings may help guide prevention efforts, according to the study.

Cigarette smoking caused the highest number of cancers and cancer-related deaths, at 19% and 29%, respectively, according to the study.

The study found that excess body weight was also a major risk factor and accounted for 7.8% of cancers and 29% of related deaths in 2014.

Exposure to UV radiation was linked to 5% of cancer cases and 1.5% of deaths, while physical activity played a role in 2.9% of cancers and 2.2% of deaths, according to the study.

When excess body weight, alcohol consumption, poor diet, and physical activity were grouped, the authors discovered that the risks were linked to 18% of cancers and 16% of deaths.

Additionally, the authors found these risk factors contributed to 100% of cervical cancers and Kaposi sarcoma and more than 75% of melanoma, anal, lung, larynx, and oral cavity cancers.

For 15 of the 26 cancer types examined, the proportion of cancer cases connected to modifiable risk factors exceeded 50%, according to the study.

The authors suggest that increased awareness and availability of prevention strategies—including taxing cigarettes and increasing HPV vaccination—could reduce the burden of preventable cancers.

Related Videos
Image credit: Dr_Microbe | stock.adobe.com
Pharmacist and patient in a retail/community pharmacy setting -- Image credit: Zamrznuti tonovi | stock.adobe.com
Related Content
Advertisement
Dry, cracked skin on finger | Image Credit: © Andriy Blokhin - stock.adobe.com
May 30th 2025

Proactive Dermatologic Care Reduces Symptom Severity and Boosts Quality of Life in NSCLC

Alexandra Gerlach, Associate Editor
Insights from a Pharmacy Times Peer Exchange: Toxicity Monitoring and Management in Real-World Settings
May 28th 2025

Insights from a Pharmacy Times Peer Exchange: Toxicity Monitoring and Management in Real-World Settings

Alexandra Gerlach, Associate Editor
TKIs binding to target proteins | Image Credit: © Justlight - stock.adobe.com
May 30th 2025

Patient Reported Outcomes Show Improved Symptoms With Zongertinib for HER2-Mutated Non-Small Cell Lung Cancer

Alexandra Gerlach, Associate Editor
pharmacy focus oncology podcast
May 19th 2025

Insights from a Pharmacy Times Peer Exchange: Real-World Outcomes and Supportive Care

Alexandra Gerlach, Associate Editor
Liver with fibrosis -- Image credit: Rasi | stock.adobe.com
May 30th 2025

Elecsys PRO-C3 Test Aims to Improve Precision Evaluation of Liver Fibrosis Severity

Gillian McGovern, Associate Editor
ASCO 2025: Pretreatment DPYD Testing for Fluoropyrimidines Can Improve Patient Safety and Lower Cost
May 29th 2025

ASCO 2025: Pretreatment DPYD Testing for Fluoropyrimidines Can Improve Patient Safety and Lower Cost

Alana Hippensteele, Lead Editor
Related Content
Advertisement
Dry, cracked skin on finger | Image Credit: © Andriy Blokhin - stock.adobe.com
May 30th 2025

Proactive Dermatologic Care Reduces Symptom Severity and Boosts Quality of Life in NSCLC

Alexandra Gerlach, Associate Editor
Insights from a Pharmacy Times Peer Exchange: Toxicity Monitoring and Management in Real-World Settings
May 28th 2025

Insights from a Pharmacy Times Peer Exchange: Toxicity Monitoring and Management in Real-World Settings

Alexandra Gerlach, Associate Editor
TKIs binding to target proteins | Image Credit: © Justlight - stock.adobe.com
May 30th 2025

Patient Reported Outcomes Show Improved Symptoms With Zongertinib for HER2-Mutated Non-Small Cell Lung Cancer

Alexandra Gerlach, Associate Editor
pharmacy focus oncology podcast
May 19th 2025

Insights from a Pharmacy Times Peer Exchange: Real-World Outcomes and Supportive Care

Alexandra Gerlach, Associate Editor
Liver with fibrosis -- Image credit: Rasi | stock.adobe.com
May 30th 2025

Elecsys PRO-C3 Test Aims to Improve Precision Evaluation of Liver Fibrosis Severity

Gillian McGovern, Associate Editor
ASCO 2025: Pretreatment DPYD Testing for Fluoropyrimidines Can Improve Patient Safety and Lower Cost
May 29th 2025

ASCO 2025: Pretreatment DPYD Testing for Fluoropyrimidines Can Improve Patient Safety and Lower Cost

Alana Hippensteele, Lead Editor
Consent Preferences
About Us
Clinical Forums
Advertise
Contact Us
Editorial Staff
Privacy Policy
Terms & Conditions
Do Not Sell My Information
Contact Info

2 Commerce Drive
Cranbury, NJ 08512

609-716-7777

Download on Apple
© 2025 MJH Life Sciences

All rights reserved.